Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.

340B Health, Researchers Spar over Biosimilar Study

September 28, 2023 Rich Daly, Editor in Chief Views

Researchers rejected criticism of a recent study in an academic journal they co-authored from the leader of a 340B hospital [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!